A dedicated life science strategy consultancy
Accelerating innovation in life science
Scientific and technological breakthroughs bring hope for treatment and cures of diseases previously untreatable. Ideas, which just a few decades ago appeared as vivid and utopian dreams, are now shaping a new reality.
A new reality for patients and their relatives. For governments, healthcare systems, and society at large. A new reality for established and upcoming life science companies that face essential new choices for how to adapt and evolve.
The life science industry is at the verge of unprecedented change. Catalyzing this change requires full attention to the big picture and the layers of complexity beneath it.
Biobridge Partners was founded to become a dedicated, integrated player in the life science ecosystem, serving pharmaceutical and biotech companies adapting for the future, and building connections between the established and the upcoming.
For you as a life science decision-maker, we want to help you solve your toughest problems, shoulder by shoulder. To help you look ahead, drive the necessary change, and prepare your company for the future.
For you as a Curious Thinker joining our team, we want to unleash your energy and drive for learning and development. To be a place for you to challenge the status quo, preparing you for a thrilling and impactful career in the life science industry.
For you as a citizen, patient or relative, we want to make a positive impact on your life by forging new partnerships and collaborations that will improve your access to innovative treatments, diagnostics, and preventive measures.
For ourselves as founders, we want Biobridge Partners to become a vehicle for delivering true and positive impact. True impact to our clients, to our team, and to society.
Jonas & Daniel
Our Core Beliefs
Learning is the only true and sustainable source of competitive advantage
Catalyzing large-scale positive change through life science requires industry-specialization
Embracing ecosystem integration and partnerships will be key in the future
Diversity of thought is a prerequisite for inspiring meaningful action and change
Daniel has 8+ years of strategy consulting experience with a predominant focus on commercial operations of life science companies. Daniel was previously part of Monitor Deloitte’s European Life Science Practice, and the Life Science Lead of Deloitte Consulting Denmark. He has deep expertise within market access, product launch, brand strategy, and customer engagement. He has experience across many therapeutic areas, and has been working with small molecules, biologics, as well as cell and gene therapies.
Daniel holds a B.Sc. in International Business and an M.Sc. in Economics and Business Administration from Copenhagen Business School.
Jonas T. Karlsen, Ph.D.
Jonas is a life science strategy consultant and a scientist with a strong analytical foundation from a Ph.D. in biophysics. Prior to co-founding Biobridge Partners, Jonas worked in Monitor Deloitte’s strategy practice, and is experienced within corporate strategy and operating model design, market access, brand strategy, and corporate M&A, as well as private equity commercial due diligence and value realization.
Jonas holds a Ph.D. in biophysics from the Technical University of Denmark, DTU, and further studied at California Institute of Technology. Recipient of the Ministry of Sciences Elite Research Award.
Florian is a life science strategy consultant with a strong background in strategy and the pharmaceutical industry from his previous positions at Novo Nordisk and Monitor Deloitte. He has 3+ years of experience working in commercial functions and global finance.
Florian holds an M.Sc. in Advanced Economics and Finance from Copenhagen Business School and a B.Sc. in Economics and Finance from the University of Strathclyde.
Johannes Bæk Christensen
Johannes is a strategy consultant with 5+ years of experience from previous positions at Monitor Deloitte and Struensee & Co. Specifically, he is experienced with corporate strategy, channel strategy, operating model design, and strategic cost out in both the public and the private sector.
Johannes holds a M.Sc. in Economics from Copenhagen University.
Mette Brøgger-Mikkelsen, M.D.
Mette is a medical doctor with a strong background at the intersection between strategy and life science. Prior to joining Biobridge Partners, Mette worked at LEO Innovation Lab and most recently as a management consultant at Bain & Company where she advised life science private equity funds. Further, Mette brings experience as a clinical physician as well as a researcher with focus on the efficiency of clinical trials.
Mette holds a M.Sc. in Medicine from the University of Copenhagen.
Olivia is a life science strategy consultant with a predominant focus on the commercial functions of biopharma companies. Prior to joining Biobridge Partners, she worked in Monitor Deloitte’s strategy practice, and is experienced within both corporate and functional strategy.
Olivia holds an MSc in Development Studies from Copenhagen University and a BSc in Economics from University of Nottingham.
Emma Jappe Lange, Ph.D.
Emma is a life science strategy consultant bringing a cross-disciplinary research background with 6+ years of experience in leading projects across machine learning, “omics”, immunology, and cancer immunotherapy.
She has worked in life science start-ups and scale-ups, primarily in the field of oncology, and has created value through scientific project management, strategy execution, as well as operating model design and implementation.
Emma holds an industrial PhD in machine learning applied to drug discovery from the Technical University of Denmark (DTU), Monash University, and Evaxion Biotech, and has gained her life science engineering degree from DTU, the University of Queensland, and University College London.
Olympio is a strategy consultant with 5 years of strategy consulting experience and a focus on life sciences. He has supported large pharmaceutical companies define their commercial access strategies in a diverse array of therapeutic areas including rare diseases, diabetes, and immunology.
Olympio holds an MEng in Computer Science from Technological University of Compiègne, and an MSc in Management from ESSEC Business School (France, Singapore) and Bocconi University (Italy, India).
Camilla drives internal operations and supports the leadership team in their day-to-day tasks. She brings several years of experience from previous positions as Communications Specialist at a Copenhagen-based scale-up and Office Manager at the Welsh Parliament.
Camilla holds a B.A. in Italian with Politics from the University of Exeter and a Management and Leadership qualification from the Chartered Management Institute.
Amadou is an intern with Biobridge Partners researching the potential of AI in drug discovery. He is in his final year of an MSc in Business Administration and Bioentrepreneurship, and his time at Biobridge will form the foundation of his master's thesis.
Amadou holds a BSc in Biotechnology from the University of Barcelona. He is particularly interested in translational medicine and its connection with early research and development in industry.
Rebecca Maria Jordan
Rebecca is an intern with Biobridge Partners researching the potential of AI in drug discovery. She is in her final year of an MSc in Business Administration and Bioentrepreneurship, and her time at Biobridge Partners will form the foundation of her master's thesis.
Rebecca holds a BSc in Biotechnology from the University of Copenhagen and is particularly fascinated by genetic engineering. She is also interested in the marketing and commercialization aspects of medical drugs and therapies, aiming to bridge the gap between science and business.
Jesper has 10+ years of experience as a life science consultant and has most recently been leading the Nordic Life Science Strategy team at Accenture. He is experienced working across the pharma value chain, with spikes in operational and commercial strategy, product launch and go-to-market strategy, and operating model design in R&D and innovation-driven organizations.
Jesper holds an Executive MBA from Copenhagen Business School.
Nicolai Hesdorf is a seasoned management consultant with over 20 years of experience working with C-suite executives at Danish C25 companies. He has held several leadership roles, including Equity Partner and Nordic Lead for Deloitte's strategy unit Monitor Deloitte and Partner and Managing Director of Accenture Denmark. Throughout his career, Nicolai has helped numerous companies develop and implement successful strategies to achieve their business goals.